A lot of scientific studies support a protective effect
of polyphenols on chronic degenerative diseases. Initially this effect was
attributed to the radical scavenging properties of these compounds but nowadays
a more complex pattern emerges. Concomitantly with the radical scavenging
properties, the in vitro effects exhibit a diminution of oxidative stress by
other pathways, in particular metal interaction and inhibition of ROS producing
enzymes such as xanthine oxidase, NADPH oxidase and lipoxygenase. There is also
evidence of processes where polyphenols act as signaling molecules. In this
pattern, the interaction decreases the inflammatory response of the bodies and
thus, the production of ROS. However the in vivo studies are not simple to
analyze and can be in contradiction with the in vitro ones. This is due to the
fact that polyphenols are metabolized during their absorption in the body. The
active molecules are no more the ingested ones.
It has been established that the dietary intake of
polyphenols ranges between 0.15 and 1 g a day. Among the polyphenols, the
flavonoids have paid a lot of attention because of its numerous properties. Theconsumption of some of them, generally as glycosylated derivatives, can attain
10-100 mg a day. However their levels rarely exceed 1 mM in human plasma. This
is the consequence of a strong and complex catabolism during digestion that has
been extensively studied by both in vitro and in vivo experiments.
No comments:
Post a Comment